1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Olfactory Disorders Global Clinical Trials Review, H2, 2014

Olfactory Disorders Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Olfactory Disorders Global Clinical Trials Review, H2, 2014" provides data on the Olfactory Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Olfactory Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Olfactory Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Olfactory Disorders Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Olfactory Disorders 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Olfactory Disorders to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Olfactory Disorders to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Drugs 22
Clinical Trial Overview of Top Institutes / Government 23
University of Washington 23
Clinical Trial Overview of University of Washington 23
University Hospitals of Leicester NHS Trust 24
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 24
National Hospital Organization 25
Clinical Trial Overview of National Hospital Organization 25
Wuhan General Hospital of Guangzhou Military Command 26
Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command 26
Saitama Medical University 27
Clinical Trial Overview of Saitama Medical University 27
The University of Tokyo Hospital 28
Clinical Trial Overview of The University of Tokyo Hospital 28
Alberta Health Services 29
Clinical Trial Overview of Alberta Health Services 29
Dresden University of Technology 30
Clinical Trial Overview of Dresden University of Technology 30
Thomas Jefferson University 31
Clinical Trial Overview of Thomas Jefferson University 31
Medical University of Vienna 32
Clinical Trial Overview of Medical University of Vienna 32
Five Key Clinical Profiles 33
Appendix 47
Abbreviations 47
Definitions 47
Research Methodology 48
Secondary Research 48
About GlobalData 49
Contact Us 49
Disclaimer 49
Source 49

List of Tables
Olfactory Disorders Therapeutics, Global, Clinical Trials by Region, 2014* 6
Olfactory Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Olfactory Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Olfactory Disorders Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Olfactory Disorders Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Olfactory Disorders Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Olfactory Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Olfactory Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Olfactory Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Olfactory Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Olfactory Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 23
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 24
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization, 2014* 25
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Wuhan General Hospital of Guangzhou Military Command, 2014* 26
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 27
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2014* 28
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014* 29
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014* 30
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 31
Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 32

List of Figures
Olfactory Disorders Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Olfactory Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Olfactory Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Olfactory Disorders Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Olfactory Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Olfactory Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Olfactory Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Olfactory Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Olfactory Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Olfactory Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
GlobalData Methodology 48

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.